Detalles de la búsqueda
1.
Combined or Sequential Treatment with Immune Checkpoint Inhibitors and Car-T Cell Therapies for the Management of Haematological Malignancies: A Systematic Review.
Int J Mol Sci;
24(19)2023 Sep 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37834228
2.
Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper.
Infection;
49(2): 215-231, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32979154
3.
Recent Bendamustine Treatment Before Apheresis Has a Negative Impact on Outcomes in Patients With Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy.
J Clin Oncol;
42(2): 205-217, 2024 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37874957
4.
Monitoring of kinetics and exhaustion markers of circulating CAR-T cells as early predictive factors in patients with B-cell malignancies.
Front Immunol;
14: 1152498, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37122702
5.
Combined treatment of graft versus host disease using donor regulatory T cells and ruxolitinib.
Sci Rep;
12(1): 8348, 2022 05 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35589917
6.
Real-world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B-cell lymphoma.
Cancer Med;
10(10): 3214-3223, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33932100
7.
Long-Term Impact of an Educational Antimicrobial Stewardship Program on Management of Patients with Hematological Diseases.
Antibiotics (Basel);
10(2)2021 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33573180
8.
Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma.
Blood Adv;
6(12): 3606-3610, 2022 06 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35271707
Resultados
1 -
8
de 8
1
Próxima >
>>